Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

2.

Present status of chemotherapy for tuberculosis.

Grosset JH.

Rev Infect Dis. 1989 Mar-Apr;11 Suppl 2:S347-52. Review.

PMID:
2652251
3.

[Treatment of tuberculosis].

Ben Amar J, Dhahri B, Aouina H, Azzabi S, Baccar MA, El Gharbi L, Bouacha H.

Rev Pneumol Clin. 2015 Apr-Jun;71(2-3):122-9. doi: 10.1016/j.pneumo.2014.09.001. Epub 2014 Nov 27. Review. French.

PMID:
25434510
4.

Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection.

Stout JE.

Expert Opin Drug Saf. 2004 May;3(3):187-98. Review.

PMID:
15155147
5.

[Antitubercular chemotherapy].

Jouveshomme S, Dautzenberg B.

Rev Mal Respir. 1997 Dec;14 Suppl 5:S88-104. Review. French.

PMID:
9496594
6.

Antituberculosis agents.

Goldberger MJ.

Med Clin North Am. 1988 May;72(3):661-8. Review.

PMID:
3280912
7.
8.

Failure of therapy for tuberculosis in human immunodeficiency virus infection.

Nolan CM.

Am J Med Sci. 1992 Sep;304(3):168-73. Review.

PMID:
1476156
9.

Antituberculosis drugs: drug interactions, adverse effects, and use in special situations. Part 1: first-line drugs.

Arbex MA, Varella Mde C, Siqueira HR, Mello FA.

J Bras Pneumol. 2010 Sep-Oct;36(5):626-40. Review. English, Portuguese.

10.

Efficacy and safety of a four-drug fixed-dose combination regimen versus separate drugs for treatment of pulmonary tuberculosis: a systematic review and meta-analysis.

Lima GC, Silva EV, Magalhães PO, Naves JS.

Braz J Microbiol. 2017 Apr - Jun;48(2):198-207. doi: 10.1016/j.bjm.2016.12.003. Epub 2016 Dec 23. Review.

11.

Leprosy and tuberculosis co-infection: clinical and immunological report of two cases and review of the literature.

Trindade MÂ, Miyamoto D, Benard G, Sakai-Valente NY, Vasconcelos Dde M, Naafs B.

Am J Trop Med Hyg. 2013 Feb;88(2):236-40. doi: 10.4269/ajtmh.2012.12-0433. Epub 2012 Dec 3. Review.

Supplemental Content

Support Center